Literature DB >> 17885262

High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: the INVADE Study.

Kerstin Sander1, Carla Schulze Horn, Claus Briesenick, Dirk Sander.   

Abstract

BACKGROUND AND
PURPOSE: High-sensitivity C-reactive protein (hsCRP) is known to be associated with atherosclerosis and cardiovascular events. Limited information exists regarding the importance of sex differences for the association between hsCRP and the progression of early stages of atherosclerosis. Therefore, we investigated the effect of hsCRP on early carotid atherosclerosis progression and major vascular risk factors in men and women.
METHODS: We analyzed the data of INVADE (intervention project on cerebrovascular diseases and dementia in the community of Ebersberg, Bavaria), a prospective, population-based study. In addition to common risk factors, measurements of carotid intima-media-thickness and hsCRP were performed at baseline and after 2 years.
RESULTS: Complete baseline data were available for 3387 subjects including 2001 women, and complete follow-up data were available for 2346 subjects. Within this study population, women were older and had higher systolic blood pressure and cholesterol levels. The prevalence of smoking and ischemic heart disease was more frequent in men. The baseline carotid intima-media-thickness was significantly higher in men compared with women (0.82 mm; 95% CI, 0.812 to 0.834 mm versus 0.77 mm; 95% CI, 0.763 to 0.779 mm; P<0.0001). Carotid intima-media-thickness progression after risk factor adjustment was significantly associated with hsCRP in women (P=0.006) but not in men (P=0.39).
CONCLUSIONS: The association between hsCRP and progression of early carotid atherosclerosis shows sex differences. In further studies analyzing the role of inflammation for cardiovascular diseases and atherosclerosis, these sex differences should be considered.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885262     DOI: 10.1161/STROKEAHA.106.481531

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Sleep disturbance in women before myocardial infarction.

Authors:  Catherine S Cole; Jean C McSweeney; Mario A Cleves; Narain Armbya; Donald L Bliwise; Christina M Pettey
Journal:  Heart Lung       Date:  2012-07-06       Impact factor: 2.210

Review 2.  Effects of exercise on c-reactive protein in healthy patients and in patients with heart disease: A meta-analysis.

Authors:  Tracy L Hammonds; Emily C Gathright; Carly M Goldstein; Marc S Penn; Joel W Hughes
Journal:  Heart Lung       Date:  2016-02-23       Impact factor: 2.210

3.  C-reactive protein in relation to early atherosclerosis and periodontitis.

Authors:  Maha Yakob; Jukka H Meurman; Tomas Jogestrand; Jacek Nowak; Per-Östen Söder; Birgitta Söder
Journal:  Clin Oral Investig       Date:  2010-12-07       Impact factor: 3.573

4.  Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis.

Authors:  Yi-Chu Liao; Hsiu-Fen Lin; Yuh-Cherng Guo; Ming-Lung Yu; Ching-Kuan Liu; Suh-Hang Hank Juo
Journal:  BMC Med Genet       Date:  2010-06-12       Impact factor: 2.103

5.  Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes.

Authors:  Nagwa A Lachine; Abdel Aziz Elnekiedy; Magdy Helmy Megallaa; Gihane I Khalil; Mohamed A Sadaka; Kamel H Rohoma; Heba S Kassab
Journal:  Ther Adv Endocrinol Metab       Date:  2016-03-10       Impact factor: 3.565

6.  Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration.

Authors:  Peter Willeit; Simon G Thompson; Stefan Agewall; Göran Bergström; Horst Bickel; Alberico L Catapano; Kuo-Liong Chien; Eric de Groot; Jean-Philippe Empana; Thorleif Etgen; Oscar H Franco; Bernhard Iglseder; Stein H Johnsen; Maryam Kavousi; Lars Lind; Jing Liu; Ellisiv B Mathiesen; Giuseppe D Norata; Michael H Olsen; Aikaterini Papagianni; Holger Poppert; Jackie F Price; Ralph L Sacco; David N Yanez; Dong Zhao; Ulf Schminke; Alpaslan Bülbül; Joseph F Polak; Matthias Sitzer; Albert Hofman; Liliana Grigore; Marcus Dörr; Ta-Chen Su; Pierre Ducimetière; Wuxiang Xie; Kimmo Ronkainen; Stefan Kiechl; Tatjana Rundek; Christine Robertson; Björn Fagerberg; Lena Bokemark; Helmuth Steinmetz; M Arfan Ikram; Henry Völzke; Hung-Ju Lin; Matthieu Plichart; Tomi-Pekka Tuomainen; Moise Desvarieux; Stela McLachlan; Caroline Schmidt; Jussi Kauhanen; Johann Willeit; Matthias W Lorenz; Dirk Sander
Journal:  Eur J Prev Cardiol       Date:  2014-11-21       Impact factor: 7.804

7.  Relationships between high-sensitive C-reactive protein and markers of arterial stiffness in hypertensive patients. Differences by sex.

Authors:  Manuel A Gomez-Marcos; Jose I Recio-Rodríguez; Maria C Patino-Alonso; Cristina Agudo-Conde; Leticia Gomez-Sanchez; Emiliano Rodriguez-Sanchez; Marta Gomez-Sanchez; Vicente Martinez-Vizcaino; Luis Garcia-Ortiz
Journal:  BMC Cardiovasc Disord       Date:  2012-06-07       Impact factor: 2.298

8.  C-reactive protein is an independent predictor for carotid artery intima-media thickness progression in asymptomatic younger adults (from the Bogalusa Heart Study).

Authors:  Ahmet Toprak; Ramprasad Kandavar; Demet Toprak; Wei Chen; Sathanur Srinivasan; Ji Hua Xu; Asif Anwar; Gerald S Berenson
Journal:  BMC Cardiovasc Disord       Date:  2011-12-30       Impact factor: 2.298

9.  Gender difference in carotid intima-media thickness in type 2 diabetic patients: a 4-year follow-up study.

Authors:  Bo Zhao; Yanping Liu; Yifei Zhang; Yuhong Chen; Zhifang Yang; Ying Zhu; Weiwei Zhan
Journal:  Cardiovasc Diabetol       Date:  2012-07-16       Impact factor: 9.951

10.  Association between C-reactive protein and coronary calcium score in coronary artery disease.

Authors:  A Hosseinsabet; A Mohebbi; A Almasi
Journal:  Cardiovasc J Afr       Date:  2009 Mar-Apr       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.